MedStar Health News | MedStar Health

Featured News

  • January 06, 2022

    Christine R. Wray announces Jan. 2022 retirement after 42 years of service in healthcare

    CLINTON, Md.Christine R. Wray, FACHE, president of MedStar Southern Maryland Hospital Center and MedStar St. Mary’s Hospital who also serves as a senior vice president for MedStar Health, announced that she will be retiring on January 28, 2022.

    Wray was named president of MedStar Southern Maryland in September 2014, two years after MedStar Health acquired the hospital located in the Clinton area of Prince George’s County. With Wray at the helm, MedStar Southern Maryland saw the development and growth of several new service lines.

    In 2016, the hospital received national recognition from U.S. News & World Report, having ranked among the top 50 of best hospitals for neurology and neurosurgery. In 2017, MedStar Southern Maryland joined the prestigious MedStar Heart and Vascular Institute-Cleveland Clinic Alliance. Wray also helped facilitate the opening of the MedStar Georgetown Cancer Institute at MedStar Southern Maryland Hospital Center in February 2020. This 25,000 square foot facility offers unmatched medical expertise, leading-edge therapies, and access to robust clinical research, all under the same roof.

    Moreover, the construction of MedStar Southern Maryland’s new Emergency Department (ED) expansion project took place under Wray’s leadership, and remained on schedule despite the COVID-19 pandemic. The $43 million ED expansion project has been deemed the largest construction project in the hospital’s history. The new emergency department opened its doors in April 2021 to provide local residents with seamless access to the most advanced care.

    Wray’s focus on providing quality care has helped MedStar Southern Maryland build a foundation of excellence that will serve local communities for decades to come. MedStar Southern Maryland is grateful for the innumerable and lasting contributions that Wray made throughout her 42-year healthcare career.

    “I have so cherished working with all of you in our commitment and service to our wonderful communities. It has truly been an honor and a privilege,” Wray said in an announcement that was emailed to hospital associates. “Please always be proud of the work you do and how you care for each other as you care for our patients. It is incredibly important work and you are the best of the best!

    Dr. Stephen Michaels, who currently serves as the chief operating and medical officer for MedStar St. Mary’s Hospital, will take over as president of MedStar Southern Maryland Hospital Center.

Share this

All News

  • January 22, 2016
    With new, and differing, mammogram and Pap screening recommendations announced by different agencies, which guidelines should you follow?
  • January 21, 2016
    A strategic partnership designed to improve the health and well-being of individuals and adults in the Waverly service area.
  • January 20, 2016

    MedStar Health at Lafayette Centre includes a national sports performance destination

    COLUMBIA, Md. —Convenient access to care, a wide range of high-quality medical, surgical and imaging services, and the radiology ct scannerstate-of-the-art sports performance center are the hallmarks of MedStar’s newest multispecialty care center, which opened today in downtown Washington, D.C.,

    MedStar Health at Lafayette Centre is home to more than 60 physicians offering 15 specialties including outpatient surgery, primary and preventive care, cardiology, urology, men’s and women’s health, and high-end imaging services. The 112,000-square-foot facility is located at 1133 21st St., NW, and offers plenty of dedicated, on-site parking.

    As an all-in-one multispecialty center, MedStar Health at Lafayette Centre offers patients the convenience of being able to get a medical image or laboratory test on the same day as their doctor’s appointment, if needed. It also provides a collaborative environment that enables clinicians to easily consult with each other in real time.

    A Game Changer

    Services include the MedStar Health Orthopaedic and Sports Center, which was designed with input from professional athletes and will serve as a national sports destination for a wide-range of individuals looking to receive care—professional athletes to collegiate and high school athletes, weekend warriors, and amateurs alike.

    The center features fellowship-trained physicians, physical therapists, and athletic trainers who will assist patients in optimizing their performance, and recovering from injuries so they can get back into the game, their weekend warrior pursuits or active lifestyle. MedStar orthopaedic and sports medicine experts are medical providers for eight professional teams, 18 colleges, and 34 area high schools. The Sports Medicine team includes 54 sports medicine physicians, 75 sports therapists and 31 athletic trainers.
 The center features a basketball court, a running track with pressure plates and a moveable pitcher’s mound, all under the surveillance of ultra-high-speed video shot from rail-mounted cameras that enable state-of-the-art motion analysis. A ballet therapy area and comprehensive rehabilitation gym are also included in the center, along with an orthopaedics clinic and state-of-the-art MRI and other diagnostic imaging modalities.

    MedStar Health at Lafayette Centre is easily accessed by Metro’s Blue, Orange and Red lines, and offers free Wi-Fi for patients’ convenience.

    About MedStar Health MedStar Health is a not-for-profit health system dedicated to caring for people in Maryland and the Washington, D.C., region, while advancing the practice of medicine through education, innovation and research. MedStar’s 30,000 associates, 6,000 affiliated physicians, 10 hospitals, ambulatory care and urgent care centers, and the MedStar Health Research Institute are recognized regionally and nationally for excellence in medical care. As the medical education and clinical partner of Georgetown University, MedStar trains more than 1,100 medical residents annually. MedStar Health’s patient-first philosophy combines care, compassion and clinical excellence with an emphasis on customer service. For more information, visit

  • January 19, 2016
    MedStar Health Research Institute was awarded grant funding for three research initiatives through the Charles and Mary Latham Fund, established by Ella O. Latham, to support medical research in the Washington, D.C., metropolitan area.
  • January 19, 2016

    MedStar Washington Hospital Center has launched the “Colon Cancer Prevention in the Neighborhood” program as part of Vice President Joe Biden’s Cancer Moonshot efforts. The program at the Hospital Center seeks to improve early detection and prevention of colon cancer, particularly among African-Americans in the Ward 5 neighborhood in Washington, D.C., where the highest yearly prevalence of colon cancer has been reported. Read more.

  • January 19, 2016
    MedStar Heart & Vascular Institute Initiates First Clinical Trial Investigating Use of Less Invasive Heart Valve Procedure for Patients at Low Risk

    Endpoint: Will TAVR Be Safe for Lower-Risk Population, Too?

    Washington, D.C., January 19, 2016 – MedStar Heart & Vascular Institute at MedStar Washington Hospital Center will be the first in the nation to launch a clinical trial, evaluating the use of a minimally invasive procedure to replace narrowed heart valves in patients who are considered at low risk for death from surgery. The Food and Drug Administration granted an Investigational Device Exemption, which allows MedStar Heart to use the investigational device in a research setting, and to enroll these patients into the study, which is starting this month.

    For decades, traditional open-heart surgery has been the gold standard for treating patients with severe aortic stenosis, an abnormal narrowing of the aortic valve in the heart. The only effective treatment is to replace the heart valve. The procedure, called TAVR, for transcatheter aortic valve replacement, is currently FDA approved for patients who are inoperable or too high-risk to undergo the open surgical procedure.

    With TAVR, instead of opening the chest, physicians insert a new valve using a catheter threaded into the heart through a small incision in the groin or chest wall.

    Trials are currently underway to investigate the use of TAVR in patients with intermediate surgical risk. However, the new study at MedStar Heart will be the first in the U.S. to investigate whether the results of TAVR in these patients are comparable to a lower-risk population.

    “We appreciate the FDA’s trust in our ability to conduct this important investigation of TAVR and its safety and efficacy in the low-risk population,” said Ron Waksman, MD, lead investigator of the study and director of Cardiovascular Research and Advanced Education at MedStar Heart & Vascular Institute. “We will be watching the results of this study closely as we strive to make minimally invasive procedures, such as TAVR, safe and effective for as many patients as possible.”

    The study is expected to enroll up to 200 patients in at least four centers across the U.S. In the trial, commercially available TAVR devices will be implanted in patients who would otherwise be candidates only for open-heart surgery. The study will compare this newly acquired TAVR data to historical controls from surgically-treated patients at each of the four sites in a patient-to-patient match.

    About MedStar Heart & Vascular Institute:

    MedStar Heart & Vascular Institute, founded at MedStar Washington Hospital Center in Washington, D.C., is a national leader in the research, diagnosis and treatment of cardiovascular disease, and has been consistently recognized by U.S. News & World Report and The Society of Thoracic Surgeons as one of the top cardiovascular programs in the nation. In January 2013, MedStar Heart formed a first-of-its-kind clinical and research alliance with world-renowned Cleveland Clinic Sydell and Arnold Miller Family Heart & Vascular Institute, the #1 heart program in the country. Together, MedStar Heart and Cleveland Clinic have forged a relationship of shared expertise that is transforming cardiovascular care, enhancing quality, improving safety and increasing access to advanced heart and vascular services. MedStar Heart & Vascular Institute comprises more than 140 cardiovascular physician specialists throughout the mid-Atlantic region, as well as the nationally recognized heart care of all nine MedStar Health acute care hospitals and MedStar National Rehabilitation Network.

MedStar Health makes the news